VanEck Associates’s Amyris Inc. AMRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-990
Closed -$2K 1451
2022
Q4
$2K Hold
990
﹤0.01% 1418
2022
Q3
$3K Sell
990
-5,613
-85% -$15.3K ﹤0.01% 1372
2022
Q2
$12K Buy
6,603
+1,871
+40% +$5.51K ﹤0.01% 1325
2022
Q1
$21K Hold
4,732
﹤0.01% 1315
2021
Q4
$26K Buy
4,732
+3,742
+378% +$34.9K ﹤0.01% 1315
2021
Q3
$14K Buy
+990
New +$14.2K ﹤0.01% 1262

Other funds holding AMRS

VanEck Associates's AMRS Position: Q1 2023 in Review

VanEck Associates sold out of Amyris Inc. (AMRS) in Q1 2023, closing a stake of 990 shares — an estimated $2K sold.

VanEck Associates first reported a position in AMRS in Q3 2021 and held it in 6 quarters. The position peaked at $26K in Q4 2021. 165 funds tracked by Wall St. Rank hold AMRS as of Q1 2023.

  • VanEck Associates reported no remaining Amyris Inc. position as of Q1 2023 after selling out during the quarter.
  • VanEck Associates sold 990 Amyris Inc. shares in Q1 2023, an estimated $2K.
  • VanEck Associates first reported a position in Amyris Inc. in Q3 2021 and held it in 6 quarters.
  • VanEck Associates's Amyris Inc. position peaked at $26K in Q4 2021.
  • 165 funds tracked by Wall St. Rank held Amyris Inc. as of Q1 2023.

Based on VanEck Associates's 13F filing for Q1 2023, filed 3 May 2023.